Immunohistochemical overexpression of BCL-2 protein predicts an inferior survival in patients with primary central nervous system diffuse large B-cell lymphoma

This study was designed to analyze the clinical characteristics and prognostic value of c-MYC and BCL-2 proteins expression in patients with primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL). 82 patients newly diagnosed with PCNS-DLBCL, from January 2008 to November 2018, wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi, Chen, Hong, Chen, Lushan, Zheng, Xiaoyun, Yang, Xiaozhu, Zheng, Zhihong, Zheng, Jing, Yang, Ting, Liu, Tingbo, Yang, Yinghong, Hu, Jianda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855480/
https://www.ncbi.nlm.nih.gov/pubmed/31702637
http://dx.doi.org/10.1097/MD.0000000000017827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855480/
https://www.ncbi.nlm.nih.gov/pubmed/31702637
http://dx.doi.org/10.1097/MD.0000000000017827

Ejemplares similares